From: Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme
Doubling time (days)
Cell line
Control
ALN
RALA/ALN
LN229
5.56 ± 0.74
5.18 ± 0.43
7.29 ± 0.36
T98G
14.00 ± 6.41
21.42 ± 8.30
–